New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
08:22 EDTTXMD, RTRXRetrophin CEO in scandal over Twitter use, TheStreet reports
Retrophin has placed the company's social media activity on "lockdown" following questionable tweets from CEO Martin Shkreli, including one that seemed to hint at a Retrophin acquisition of an approved drug from a private company, reported TheStreet's Adam Feuerstein. The social media blackout also follows the discovery that employees were using Twitter aliases to promote Retrophin and pitch short-sale recommendations of other stocks, including a tweet that singled out TherapeuticsMD (TXMD), the report added. Reference Link
News For RTRX;TXMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
17:02 EDTTXMDTherapeuticsMD files $100M mixed securities shelf
Subscribe for More Information
December 18, 2014
07:46 EDTRTRXRetrophin management to meet with Deutsche Bank
Meeting to be held in Baltimore on December 18 hosted by Deutsche Bank.
December 16, 2014
08:02 EDTRTRXRetrophin announces addition to NASDAQ Biotechnology Index
Subscribe for More Information
December 15, 2014
16:19 EDTTXMDTherapeuticsMD receives five new patent allowances
Subscribe for More Information
December 11, 2014
07:22 EDTRTRXRetrophin management to meet with Deutsche Bank
Subscribe for More Information
December 10, 2014
07:25 EDTRTRXRetrophin management to meet with Deutsche Bank
Meeting to be held in New York on December 10 hosted by Deutsche Bank.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use